Natural Course of Adult Ebstein Anomaly When Treated according to Current Recommendation

• Published in: Journal of Korean medical science Vol. 31; no. 11; pp. 1749 - 1754
• Main Authors: Kim, Hyung Yoon, Jang, Shin Yi, Moon, Ju Ryoung, Kim, Eun Kyoung, Chang, Sung-A, Song, Jinyoung, Huh, June, Kang, I-Seok, Yang, Ji-Hyuk, Jun, Tae-Gook, Park, Seung Woo
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Academy of Medical Sciences 01.11.2016; 대한의학회
• Subjects: Adolescent; Adult; Aged; Arrhythmias, Cardiac - etiology; Cerebrovascular Disorders - etiology; Disease-Free Survival; Ebstein Anomaly - mortality; Ebstein Anomaly - pathology; Ebstein Anomaly - surgery; Echocardiography; Female; Heart - diagnostic imaging; Heart Failure - etiology; Humans; Male; Middle Aged; Original; Proportional Hazards Models; Reoperation; Retrospective Studies; Treatment Outcome; Young Adult; 의학일반; Clinical Outcome; Ebstein Anomaly; Adults; Treatment
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2016.31.11.1749

The objectives of this study were to assess the clinical outcomes of adults with Ebstein Anomaly (EA) according to their treatment modalities. All adult EA patients diagnosed between October 1994 and October 2014 were retrospectively evaluated by medical record review. Total 60 patients were categorized into 3 groups according to their treatment strategy, i.e. non-operative treatment (Group I, n = 23), immediate operative treatment (Group II, n = 27), and delayed operative treatment (Group III, n = 10). A composite of major adverse cardiac and cerebrovascular events (MACCE) and factors associated with MACCE were assessed in each treatment group. MACCE occurred in 13.0% patients in Group I, 55.6% patients in Group II and 50% in Group III (P = 0.006). Event free survivals at 5 years were 90% in Group I, 52.7% in Group II, 50.0% in Group III (P = 0.036). Post-operatively, most patients showed improvement on clinical symptoms. However, event free survival rate was lower in patients with operation compared to those with non-operative treatment (58.7% vs. 90.9%; P = 0.007). Major arrhythmic event occurred more frequently even after surgical ablation (50.0% vs. 20.0%; P = 0.034). Re-operation was more frequent in patients underwent delayed surgery compared to those with immediate surgery (50.0% vs. 18.5%; P = 0.001). Current guideline to decide patient's treatment strategy appeared to be appropriate in adult patients with EA. However, surgical ablation for arrhythmia was not enough so that concomitant medical treatment should be considered. Therefore, attentive risk stratification and cautious decision of treatment strategy by experienced cardiac surgeon are believed to improve clinical outcome.